Literatur – 2. Erhoffte, aber nicht eingetretene Wirkungen

1. Gilbert R, Salanti G, Harden M, et al. Infant sleeping position and the sudden infant death syndrome: systematic review of observational studies and historical review of clinicians’ recommendations from 1940–2000. International Journal of Epidemiology 2005; 34: 74–87.

2. Furberg CD. Effect of antiarrhythmic drugs on mortality after myocardial infarction. American Journal of Cardiology 1983; 52: 32C–36C.

3. Chalmers I. In the dark. Drug companies should be forced to publish all the results of clinical trials. How else can we know the truth about their products? New Scientist 2004, 6. März, S. 19. Darin zitiert: Moore T, Deadly Medicine. New York: Simon and Schuster, 1995.

4. Cowley AJ, Skene A, Stainer K, et al. The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias. International Journal of Cardiology 1993; 40: 161–166.

5. Chalmers I. Evaluating the effects of care during pregnancy and childbirth. In: Chalmers I, Enkin M, Keirse MJNC, eds. Effective care in pregnancy and childbirth. Oxford: Oxford University Press, 1989: 3–38.

6. Ulfelder H. The stilbestrol disorders in historical perspective. Cancer 1980; 45: 3008–3011.

7. Office of Technology Assessment. Identifying health technologies that work: searching for evidence. Washington, DC: US Government Printing Office, 1994.

8. Hemminki E, McPherson K. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. BMJ 1997; 315: 149–153.

9. Anonymous. HRT: update on the risk of breast cancer and long-term safety. Current Problems in Pharmacovigilance 2003; 29: 1–3. Zitiert werden darin die Ergebnisse der randomisierten kontrollierten Studie der Women’s Health Initiative (JAMA 2003; 289: 3243–3253) sowie der Million Women Study (Lancet 2003; 362: 419–427).

10. Roberts H. Hormone replacement therapy comes full circle. BMJ 2007; 335: 219–220.

11. Williams HC. Evening primrose oil for atopic dermatitis: time to say goodnight (editorial). BMJ 2003; 327: 1358–1359.

12. Hoare C, Li Wan Po A, Williams H. Systematic review of treatment for atopic eczema. Health Technology Assessment 2000; 4(37): 1–191.

13. Takwale A, Tan E, Agarwal S, et al. Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial. BMJ 2003; 327: 1385–1387.